Proteogenix Raises $20 Million

Proteogenix Inc., a Portland, Ore.-based developer of proteomic and genomic tests to detect and monitor fetal disorders , has raised $20 million in Series B funding, according to a regulatory filing. Backers include Burrill & Co., New Leaf Ventures and TPG Ventures. www.proteogenix.com